Sort
21,281 grants matching “influenza”
Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by pulmonary delivery of engineered Influenza A Virus (eIAV)
$399,999Mallikarjun Srivatsan · Accurius Therapeutics, Inc. · R44 · FY2023 · CA
US-Cuba Administrative Supplement to the Viral Immunity and Vaccination (VIVA) Human Immunology Project Consortium
$399,999Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
The INFLUENTIAL Trial- Inpatient FLU Vaccination Program Effectiveness: National Trial Implementing Best Practices And Learning Collaboratives
$399,998Suchitra Rao · University Of Colorado Denver · R18 · FY2024 · HS
The INFLUENTIAL Trial- Inpatient FLU Vaccination Program Effectiveness: National Trial Implementing Best Practices And Learning Collaboratives
$399,998Suchitra Rao · University Of Colorado Denver · R18 · FY2023 · HS
Joint Initiative in Vaccine Economics (JIVE) Project, Phase 3
$399,934Tracy A Lieu · Harvard Pilgrim Health Care, Inc. · U01 · FY2009 · IP
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
$399,931Peter C Doherty · St. Jude Children'S Research Hospital · R01 · FY2007 · AI
DEVELOPING SUSTAINABLE INFLUENZA NETWORKS AND RESPONSE TO AVIAN AND PANDEMIC INFL
$399,865Lorenz Benzler · Secretariat Of The Pacific Community · U51 · FY2010 · IP
Visualizing Effects of Costimulation on Antiviral Immunity
$399,833Arlene H Sharpe · Harvard Medical School · P01 · FY2009 · AI
Duke Infectious Disease Response Training Consortium (DIDRT)
$399,831Gregory D Sempowski · Duke University · UH4 · FY2017 · ES
The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Pers
$399,818Kathryn Margaret Edwards · Vanderbilt University · U18 · FY2010 · IP
Fc Receptor Signaling in Vaccine Design for the Elderly
$399,798Biao Zheng · Baylor College Of Medicine · R01 · FY2007 · AI
Endothelial antigen presentation to T cells as a pathogenic mechanism in influenza-induced acute lung injury.
$399,750Lianghui Zhang · University Of Illinois At Chicago · R01 · FY2021 · HL
HIV-1 Env gp160 maturation in the Golgi apparatus
$399,750Yong-Hui Zheng · University Of Illinois At Chicago · U01 · FY2024 · AI
T cell immunity to influenza virus in the aged nasal mucosa
$399,750Bas Baaten · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · AG
T cell immunity to influenza virus in the aged nasal mucosa
$399,750Bas Baaten · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · AG
HIV-1 Env gp160 maturation in the Golgi apparatus
$399,750Yong-Hui Zheng · University Of Illinois At Chicago · U01 · FY2025 · AI
HIV-1 Env gp160 maturation in the Golgi apparatus
$399,750Yong-Hui Zheng · University Of Illinois At Chicago · U01 · FY2023 · AI
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
$399,739Balaji Manicassamy · University Of Chicago · R01 · FY2018 · AI
Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
$399,699Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2020 · IP
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
$399,643William H Robinson · Stanford University · R33 · FY2015 · CA
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
$399,643William H Robinson · Stanford University · R33 · FY2014 · CA
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
$399,643William H Robinson · Stanford University · R33 · FY2016 · CA
Simultaneous antigen receptor repertoire profiling and single-cell transcriptomics in T and B lymphocytes from limited clinical samples
$399,581Steven Edward Bosinger · Emory University · U24 · FY2015 · AI
Epigenetic Regulation of Plasma Cell Differentiation
$399,547Jeremy M. Boss · Emory University · P01 · FY2016 · AI
Joint Initiative in Vaccine Economics (JIVE) Project, Phase 3
$399,528Tracy A Lieu · Harvard Pilgrim Health Care, Inc. · U01 · FY2007 · IP